Open access

Advances in Comprehensive Pulmonary Rehabilitation for COPD Patients

Written By

R. Martín-Valero, M.C. Rodríguez-Martínez, R. Cantero-Tellez, E. Villanueva-Calvero and F. Fernández-Martín

Submitted: September 18th, 2013 Published: July 16th, 2014

DOI: 10.5772/57563

Chapter metrics overview

2,077 Chapter Downloads

View Full Metrics

1. Introduction

Physical inactivity (lack of exertional pursuits) is the fourth leading risk factor for mortality worldwide and contributes to 6% of all deaths. Only hypertension, smoking, and diabetes are associated with greater mortality [1]. In addition, nearly 5% of worldwide mortality is caused by excessive weight [2]. Numerous prospective, observational studies suggest that the least active and unfit people are at the greatest risk for developing a variety of chronic diseases [3]. Physical inactivity has been identified as an independent risk factor for cardiovascular disease, diabetes, hypertension, obesity, osteoporosis, colon, breast and other cancers, depression, anxiety and other illnesses [4].

Chronic Obstructive Pulmonary disease (COPD) is the most common chronic lung disease and is the fourth leading cause of death in the world. COPD has a high impact on patients´ wellbeing, health care utilization, and mortality [5] and causes a substantial and increasing economic and social burden [6, 7].

As COPD worsens and individuals experience increasing respiratory symptoms, a vicious cycle develops whereby activity declines, walking speed is reduced, fitness levels decline, and activities of daily living become too difficult to carry out, eventually causing disability and dependence [8]. Physical activity is reduced in severe COPD [9] but the level of activity in individuals with moderate COPD is less well studied. Hence, inactivity may not only be a manifestation of disease severity in COPD but may also contribute to disease progression [10]. In a recent study of the patterns of physical activity including the frequency, duration and intensity of episodes of physical activity, patients with COPD wore the SenseWear® armband acelerometer for eight consecutive days [11]. With increasing COPD severity, time in physical activity, proportion of time performing activities, and frequency of activity decreased. These objective outcomes provide the best measures of physical activity [12].

COPD is characterized by inexorably progressive, non-normalizing airflow limitation and the severity of obstruction correlates with its morbidity and mortality [5, 13]. Based upon the presence of oxidative stress, increased levels of circulating cytokines, and multiple nonpulmonary manifestations, COPD is increasingly being recognized as a systemic disorder [5]. Furthermore, COPD does not manifest in a homogeneous manner and many different subgroups or phenotypes are being recognized. The polysystemic manifestations and heterogeneity of clinical and inflammatory profile presentations of COPD have led to an expanded classification in the most recent GOLD guidelines that incorporate clinical manifestations including effects on physical activity and healthcare utilization or risk in addition to physiologic impairment [5]. This multifactorial classification is used to stage COPD severity and to guide and monitor treatment [5]. In addition, the clinical course of patients with COPD is marked by repetitive exacerbations and abnormal inflammatory response which further contribute to a downward spiral of physical activity [5, 14].

Decreased caloric intake leading to nutritional depletion occurs in about 20-35% of outpatients with COPD and up to 70% of patients with acute respiratory failure or waiting for lung transplantation [15]. Cachexia, defined as weight loss with disproportional fat-free mass wasting, occurs in about one-third of patients with COPD eligible for pulmonary rehabilitation and represents a cause of increased mortality independent of ventilatory limitation [16].


2. Biochemical changes

Many of the major pathophysiologic derangements in advanced COPD have been attributed to systemic inflammation [17]. Previous studies show that systematic inflammation is induced by inflammatory cytokines, such as tumor necrosis factor (TNF-α), interleukin (IL-6) and IL-8 [18, 19]. Fat-free mass (FFM) depletion marks the imbalance between tissue protein synthesis and breakdown that occurs in COPD [20]. These inflammatory cytokines and endocrine hormones contribute to the reduction in exercise tolerance and poor quality of life caused by skeletal myopathy in COPD patients [21]. Skeletal muscle dysfunction plays an important role in the symptoms and impairments in strength, endurance, and maximal exercise capacity experienced by patients [22].

Bronchiectasis, permanent damage and widening of one or more of the large connecting bronchi (airways), may occur in nearly one third of individuals with COPD [22]. Individuals with bronchiectasis have elevated levels of proinflammatory cytokines that are associated with decreased fat-free mass, increased proteolysis and worse respiratory function [22-24]. This chronic inflammation increases the levels of oxidative stress [25, 26]. Circulating (plasma) and intracellular biomarkers of oxidative stress are increased in patients with bronchiectasis compared with control subjects [25].

Decline in nutritional status is directly related to lung function outcomes and has been proposed as a predictor of morbidity and even mortality in patients with chronic respiratory diseases independent of the ventilatory limitation [15]. Furthermore, malnutrition is accompanied by a loss of diaphragmatic and structural skeletal muscle mass, as well as humoral and cellular dysfunction [15]. Anabolic stimulation through a combination of nutritional support and exercise appears to be the best approach to improving functional status [27]. A multicenter study of stable COPD patients with a body mass index of 22 kg/m2 and a fat-free mass index of 16 showed that the consumption of oral nutritional supplements, rich in proteins (with 50% of whey protein) produced a significant improvement in quality of life [28]. A subsequent Cochrane Database meta-analysis showed that undernourished patients with COPD improved with nutritional supplementation [29]. Malnourished patients who received supplementation had significantly better maximum inspiratory pressures and maximum expiratory pressures [29].

Thus, impaired skeletal muscle function is a potentially remediable systemic manifestation of COPD [30]. These findings have implications for identification of drug targets aimed at improving muscle function in COPD [30]. Except for markers of myogenesis, molecular responses to resistance training are not tightly coupled to lean mass gains [30].


3. Management of comprehensive pulmonary rehabilitation

Pulmonary Rehabilitation (PR) has become a cornerstone in the management of patients with stable COPD in recent years [31]. Systematic reviews show large and important clinical effects of PR in these patients [32]. PR improves anxiety and depression in patients with COPD [33]. PR also reduces the number and duration of hospitalizations [34, 35]. In addition, physical training and chest physiotherapy in respiratory disease have long-term, durable benefits [36-38]. The components of PR vary widely but a comprehensive program includes smoking cessation, education, nutrition counseling, and exercise training [5].

3.1. Educational and nutritional management

All patients enrolled in PR should receive educational and nutritional interventions as part of an integrated care plan that seeks to achieve a normal nutritional status, either through natural diet or supplements [15, 39]. Nutrition depletion occurs by multiple mechanisms including energy imbalance, disuse atrophy of the muscles, hypoxemia, systemic inflammation and oxidative stress [15]. Each of these mechanisms may represent targets for nutritional intervention.

Patients with COPD are best managed through multimodal therapies delivered through an integrated healthcare system [40]. Dietary supplementation with whey may potentiate the effects of exercise training on exercise tolerance and quality of life in patients with COPD [41]. Use of a nutritional supplement containing anti-inflammatory whey peptide with exercise therapy in stable elderly COPD patients increased body weight, reduced markers of systemic inflammation, and improved exercise levels and respiratory health [17].

There is a clear need for adequately powered and controlled intervention and maintenance trials to establish the role of nutritional supplementation in the enhancement of exercise performance and training and wider management of the systemic features of COPD [40]. Hence, combination therapy, nutritional, pharmacologic, and physical training, may produce weight gain, increases in lean mass, respiratory muscle strength, exercise capacity, lung function, and respiratory health while reducing morbidity and mortality. Physiotherapy, occupational therapy, and medical treatment are individually adjusted to each patient’s needs and requirements with the goal of improving current quality of life and these targets should be re-adjusted when patients opt for palliative care [42].

Although prior reviews did not provide evidence for the usefulness of nutritional supplementation therapy, more recent analyses concluded that nutritional supplemental therapy increased weight, fat free mass, exercise tolerance, and hand grip strength in undernourished patients with COPD [29, 43, 44]. High calorie nutrition therapy and L-carnitine supplementation may be beneficial whereas no effect is observed with additional creatine [45]. The duration and type of exercise may also affect PR results. Although both low and high intensity exercise training are beneficial for patients with COPD, higher intensity lower extremity exercise yields better physiologic improvement than lower intensity exercise [46]. PR programs that are 12 weeks or longer produce enhanced and more durable results than shorter programs [43, 46]. The benefits of PR tend to wane gradually over 12 to 18 months [43, 46].

3.2. Importance of exercise training

There are two different types of Physical Exercise Training for COPD patients: endurance and interval type training [47]. Endurance or continuous programmes include constant load and incremental load training. However, patients with symptoms of severe dysnea during exercises were incapable of performing high-intensity (70 to 80 % of the peak work rate) continuous type training. Interval training is recommended as an alternative to continuous training in patients with severe symptoms of dyspnoea during exercise due to an inability to sustain continuous training at the recommended intensities. During interval training short exercise bouts (30-180 seconds) are performed at high intensity (at least 70-80% of peak work rate). Recommended frequency of training is the same as with continuous training [47]. Finally, there is evidence that regular physical activity contributes to the primary and secondary prevention of several chronic diseases and is associated with a reduced risk of premature death [48].

Physical activity is defined as any bodily movement produced by the contraction of skeletal muscle that increases energy expenditure above a basal level [49]. Exercise therapy is defined as a subcategory of physical activity in which planned, structured, and repetitive bodily movements are performed to maintain or improve one or more attributes of physical fitness [49]. Physical fitness refers to the ability to carry out daily tasks with vigor and alertness without undue fatigue and with ample energy to enjoy leisure time pursuits and to meet unforeseen emergencies [49].

Physical activity is the strongest predictor of all-cause mortality in patients with COPD [50]. Nowadays, lack of physical activity is associated with the burden of chronic disease [51]. The low levels of Physical Activity (PA) generally observed in people with COPD may be due in part to the difficulties they experience as they attempt to perform daily activities that they need and want to perform [14]. Importantly, physical inactivity is potentially reversible [52].

There is strong evidence that community physiotherapy benefits health by promoting physical activity [8, 53]. Exercise prescribed by a physiotherapist can target directly any impairments contributing to activity limitations and requires the active participation of subjects in an individualized physical exercise program [53]. Exercise training can produce significant improvement in health related quality of life, exercise capacity, respiratory muscle strength, and exertional dyspnea in patients with COPD who have normal exercise capacity [54]. Hence, enrollment in a comprehensive Pulmonary Rehabilitation Program (PRP) that includes exercise training and dietary supplementation may benefit patients with COPD. PRP may be supported by motivational counseling [55]. Furthermore, physical activity is an attractive outcome measure for interventional studies in patients with COPD.

Both physical activity and daily exercise improve the health of COPD patients [10]. It is necessary to avoid a sedentary lifestyle and encourage them to perform physical activity and exercises [10]. The performance of regular physical activity by patients with COPD reduces the risk of both hospital admissions and all-cause and respiratory mortality [10]. It appears that patients with COPD have a significantly reduced duration, intensity, and number of daily physical activities when compared with healthy control subjects [56]. Hence, the recommendation that COPD patients be encouraged to maintain or increase their levels of regular physical activity should be considered in future research [10]. A Spanish research group developed a novel alternative to formal PRP that includes a walking training circuit in the city of Catalonia [57] that has been replicated in other cities such as Navarre [58] (Figure 1).

Figure 1.

Walking circuits from “Walking Guide for COPD patients” [58]

3.3. Oxygen therapy

Oxygen theray is one of the therapies currently available to reduce COPD mortality [59]. Long-term oxygen therapy (LTOT) reduces pulmonary hypertension and improves survival in patients with COPD and resting hypoxemia (arterial partial pressure of oxygen ≤55 mmHg) [60].

The use of oxygen supplementation during exercise training for individuals with COPD is unclear [61]. Supplemental oxygen during exercise training improves functional outcomes such as symptoms, health-related quality of life, and ambulation [61]. However, there are no significant differences in maximal exercise outcomes, functional exercise outcomes (six-minute walk test), shuttle walk distance, health-related quality of life, or oxygenation status [61, 62].

COPD patients with low fat-free mass (FFM) have lower levels of oxidative stress with supplemental oxygen [63]. Patients with COPD are able to achieve a higher work rate during exercise training, which positively affects training results after several weeks [64]. It is generally recommended that COPD patients who are already hypoxaemic at rest should use oxygen during exercise, aiming at a rather arbitrary oxygen saturation of > 90% [64]. A review of the effect of oxygen in COPD patients with or without desaturation during exercise training concluded that hyperoxia has no clear effect on the results of exercise training in COPD patients with or without documented desaturation during exercise [64]. Only one study demonstrated a significant, and clinically relevant, improvement in higher work load during rehabilitation [65]. In conclusion, more studies are needed to define the role of supplemental oxygen in PR; for instance, on the oxygen concentration, intensity of exercise programmes, and its effects in different COPD phenotypes.


4. Measuring and improving the physical activity level in COPD patients?

Exercise tolerance is a well accepted clinical marker in COPD and provides information about disease stage, prognosis, functional capacity, and the effects of treatment [66]. The assessment of physical activity in healthy populations and in those with chronic diseases is challenging. Furthermore, physical activity is most accurately measured using objective tools such as accelerometer-based activity monitors [67]. In addition, other outcomes must be included, such as quadriceps and grip strength [68].

Physical activity monitors are frequently used to estimate levels of daily physical activity [69]. These devices use piezoelectric accelerometers, which measure the body´s acceleration, in one, two or three axes (uniaxial, biaxial or triaxial activity monitors). The signal can then be transformed into an estimate of energy expenditure using one of a variety of algorithms, or summarized as activity counts or vector magnitude units (reflecting acceleration) [69]. With the information obtained in the vertical plane or through pattern recognition, steps or walking time can also be derived from some monitors [69].

A systematic review identifies the available activity monitors that have been appropriately validated for use in assessing physical activity in these groups [70]. Forty monitors were tested in validation studies; 12 uniaxial, 3 biaxial, 16 triaxial accelerometers and 9 multisensor devices [70]. Furthermore, a recent study evaluated the validity and usability of six activity monitors in COPD patients against the double labelled water indirect calorimetry method [71]. The Actigraph GT3X and DynaPort MoveMonitor best explained the majority of the total energy expenditure variance not explained by total body water and showed the most significant correlations with activity energy expenditure [71].

Moreover, the Dynaport MiniMod and Actigraph GT3X discriminate best between different walking speeds [69]. Overall, these findings should guide the choice of valid activity monitors for research or for clinical use in patients with chronic diseases such as COPD. In a recent comparison, two types of accelerometer: the DynaPort and the Actiwatch were used in order to assess the level of physical activity [12] and compared with a multisensory armband device (SenseWear, BodyMedia; Pittsburgh, PA) [9]. The main finding of this pilot-study was the significant reduction in physical activity observed with each patient. The study provides evidence for a gradual reduction in daily physical activity levels with increasing GOLD stage, although the correlation between physical activity and lung function is weak [9].


5. Does the choice for inspiratory or expiratory muscle strength or endurance training matter?

COPD alters muscle structure and/or functional. Strength and endurance are the two main functional properties of both respiratory and peripheral muscles and reduction in either strength or endurance leads to muscle dysfunction. Strength mainly depends on muscle mass, and endurance is related to muscle fiber aerobic properties [72]. Muscle weakness is a relatively stable condition related to the loss of muscle strength which requires long-term therapeutic measures (training and/or nutritional interventions). In contrast, muscle fatigue is a temporary dysfunction related to endurance [73]. Many COPD patients experience muscle dysfunction and reduced muscle mass, primarily as a result of chronic immobilization [74]. Over the last decade, the potential use of resistance training for COPD has gained increasing attention.

A Cochrane Database Systematic Review showed that breathing exercises over four to 15 weeks improve functional exercise capacity in people with COPD compared to no intervention; however, there were no consistent and clear effects on dysnoea or health-related quality of life [75].

Muscle strength can be measured by the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) [76]. Inspiratory muscle training (IMT) provides breathing training together with resistance loading produced by a valve and is regarded as a mixture of strength and endurance training. IMT may improve inspiratory muscle strength, endurance, functional exercise capacity, dyspnoea, and quality of life. A question to be taken into account in the planning of a respiratory muscles training protocol in COPD patients would be to determine which is more important, inspiratory muscle strength training or endurance training. A meta-analysis showed that inspiratory muscle endurance training was less effective than respiratory muscle strength training [76]. Both types of training (strength and endurance) significantly improve the endurance of the muscles, but only strength training was able to significantly improve the MIP, the MEP and functional exercise capacity [76].

Although many resistance devices are available, the Threshold-IMT® is frequently used and produces loads of 7-41 cm H2O. The devices produce a range of resistance levels, with lower resistance levels offered by the Threshold Inspiratory Muscle Trainer (Phillips Respironics, Murrysville, PA) and higher resistance levels offered by the POWERBreathe® (HaB International Ltd, Southam, Warwickshire, UK) and the PowerLung® (PowerLung, Houston, TX). The POWERBreathe® is only for inspiratory muscle training and has three models. The Light POWERbreathe® produces loads of 17-98 cm H2O, the medium device delivers loads of 23-186 cm H2O, and the heavy device achieves loads of 29-274 cm H2O. The PowerLung® is for inspiratory and expiratory muscles training and has four models that produce varying levels of resistance [72].

The Orygen-Dual Valve® was designed and patented by researchers of Barcelona and allows both simultaneous and sequential dual training work (expiratory and inspiratory muscles) (Figure 2) [72]. The Orygen-Dual Valve® is a relatively cheap, portable, and easy to use piece of equipment that provides workloads up to 70 cm H2O at a rate of 15-20 breaths/min [72].

Figure 2.

Martín-Valero, R. makes the rehabilitation programme with Orygen-Dual Valve®

High-intensity inspiratory muscle training improved inspiratory muscle function in subjects with moderate-to-severe COPD, producing significant reductions in dyspnoea and fatigue [77]. In addition, a 4-week supervised high-intensity respiratory training program in patients with COPD demonstrated functional improvements [78, 79]. The Orygen-Dual Valve® makes the rehabilitation programme more efficient than usual training as it requires fewer resources in terms of time and staff, and allows patients to acquire skills for further training outside the Hospital [68]. Furthermore, the hi-IMT achieves this result in a shorter time, which is an advantage for improving the efficiency of rehabilitation programmes within the public health system [72]. The training must be supervised by a therapist once a week during the first month.

The addition of high-intensity IMT to aerobic exercise produced incremental benefits in muscle weakness, cardiopulmonary function, and health-related quality of life in a randomized study of patients with chronic heart failure [80]. A multicenter randomized controlled trial is currently underway to determine whether the addition of IMT to a general exercise training program improves the distance walked in six minutes, health related quality of life, daily physical activity, and inspiratory muscle function in individuals with COPD and reduced inspiratory muscle strength [81].


6. What are the views and perceptions of people with COPD regarding a pumonary rehabilitacion?

Individuals with COPD people who complete a course of PR believe that ongoing structured exercise with professional and peer support assists them with continued regular exercise [82]. However, patients with COPD often encounter potential barriers to PR attendance including difficulties with travel to exercise venues, fluctuating health status with respiratory symptoms that impede physical activity, and psychological emotional effects including feelings of embarrassment [82, 83].

Many qualitative studies of PR in patients with COPD have been performed over the past decade to determine the impressions and opinions of PR participants. There are two main theories that have been used to analyse qualitative research [88, 89]. The first one is known as the grounded theory approach [90] and the second theory is the interpretative phenomenological analysis framework [88, 89, 91]. Qualitative research uses data collected from focus groups [82, 92], semi-structured interviews [87, 93, 94] or a combination of both methods [92, 95]. Some studies use triangulation research (96) or embed a qualitative study in a randomized controlled trial in order to explore patients’ views on self-management [97]. The main areas of research were: the effect of people´s health status on exercise adherence [82], pain (85), and social relationships, such as social integration and social support [86].

It is necessary to increase strategies for self motivation among individuals with COPD [87]. Encouraging health behaviours is a key feature relating to PR participation including physical activity and smoking reduction or cessation [55]. Telephone delivery of health-mentoring is feasible and acceptable to individuals with COPD in primary care and may improve PR participation [55]. Telemonitoring of individuals with COPD enhanced self-management by improving patients’ knowledge about their disease [97].


7. Occupational therapy in COPD

Patients with COPD may benefit from occupational therapy as well as physical therapy. However, there are few studies evaluating occupational therapy for individuals with COPD. A qualitative study suggested that occupational therapy may reduce breathlessness, improve mental outlook, and increase the confidence of individuals with COPD [84].

In the future, occupational therapists may be able to assess and provide rehabilitation interventions for patients with COPD [98]. Incorporation of occupational therapy in PR may increase patients’ knowledge of COPD, elevate their sense of control, promote re-engagement in activities, reduce anxiety, and improve social engagement [98].

Theoretical and clinical occupational therapy supports a rehabilitation model based on continued participation in activities that are considered essential in the life of the person [99]. The respiratory symptoms of patients with COPD have an impact on activities of daily living. Occupational therapy interventions in patients with COPD aim to develop specific strategies to perform basic activities of daily living, and leisure activities, so that they involve the least possible waste of energy [100]. Through energy saving techniques, Occupational Therapy aims to reduce the patient's subjective respiratory distress. In activities of daily living training, patients learn to work efficiency and also learn economies of movement, minimizing the energy cost of dressing, personal hygiene, home care, leisure activities, shopping, and other activities related to the patients´ work [100]. Although simple, energy saving techniques require a learning process that is difficult to achieve outside of a multidisciplinary rehabilitation program [100].

Research into COPD’s psychological effects on patients’ ability to perform daily activities provides a wholistic approach to COPD and its consequences. The Occupational Therapy framework provides a basis for the design of a comprehensive PR intervention that addresses all aspects of a patient’s life. Recent research shows that optimization of occupational performance improves the welfare of individuals with COPD [101]. Members of the patient’s social network should not be excluded from these plans and interventions. Application of a family psychoeducational program based in training and information about COPD pathology including risk factors, habits that facilitate disease progression, specific strategies for handling the problems of daily life, and how to face the difficulties in occupational performance for each stage of the disease may empower the patient’s friends and family to assist with rehabilitation [102]. An initial interview with the patient, family, and friends is the initial step to developing a comprehensive PR program that includes all members of the patients’ social network [103].


8. Conclusion

In conclusion, a multidimensional therapeutic approach is recommended for developing a comprehensive pulmonary rehabilitation program for patients with COPD. Critical elements of PR include optimization of pharmacologic and nonpharmacologic management, exercise, physical activity, ventilatory support, nutritional, and occupational therapy interventions. In addition, there is a need for new models for pulmonary rehabilitation which allow all program components to be delivered at home, with proven clinical outcomes and low costs [104]. It is possible that undertaking pulmonary rehabilitation within the home environment may promote more effective integration of exercise routines into daily life over the longer term with greater adherence to exercise [104]. In fact, home-based exercise programs achieve equivalent clinical outcomes and are cost effective compared with hospital-based programs. The decentralization of pulmonary rehabilitation increases the options for its provision and may assist in overcoming the most frequently identified barriers to pulmonary rehabilitation [104].


  1. 1. Global Health risks: mortality and burden of disease atributable to selected major risks. Geneva: Organización Mundial de la Salud; 2009.
  2. 2. Estadísticas Sanitarias Mundiales 2011. 2011; Available at: Accessed 03/01, 2012.
  3. 3. Haskell WL, Blair SN, Hill JO. Physical activity: health outcomes and importance for public health policy. Prev Med 2009;49(4):280-282.
  4. 4. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007 Aug;39(8):1423-1434.
  5. 5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2013.
  6. 6. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006 Feb;27(2):397-412.
  7. 7. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006 Nov;3(11):e442.
  8. 8. Wittink H, Engelbert R, Takken T. The dangers of inactivity; exercise and inactivity physiology for the manual therapist. Man Ther 2011 Jun;16(3):209-216.
  9. 9. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010 Jul;104(7):1005-1011.
  10. 10. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006 Sep;61(9):772-778.
  11. 11. Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, Rodriguez DA, Farrero E, Batlle JD, et al. Physical activity in COPD patients: patterns and bouts. Eur Respir J 2012 Dec 20.
  12. 12. Stuart Albert P. Physical Activity Monitoring in COPD patients. University of Liverpool 2012.
  13. 13. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006 May 1;173(9):985-990.
  14. 14. ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD 2007 Sep;4(3):293-297.
  15. 15. Aniwidyaningsih W, Varraso R, Cano N, Pison C. Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care 2008 Jul;11(4):435-442.
  16. 16. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993 May;147(5):1151-1156.
  17. 17. Sugawara K, Takahashi H, Kashiwagura T, Yamada K, Yanagida S, Homma M, et al. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respir Med 2012 Nov;106(11):1526-1534.
  18. 18. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996 Aug;51(8):819-824.
  19. 19. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006 Jan;61(1):17-22.
  20. 20. Baldi S, Aquilani R, Pinna GD, Poggi P, De Martini A, Bruschi C. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis 2010 Feb 18;5:29-39.
  21. 21. Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002 Aug 15;166(4):485-489.
  22. 22. Vendrell M, de Gracia J, Olveira C, Martinez MA, Giron R, Maiz L, et al. Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery. Arch Bronconeumol 2008 Nov;44(11):629-640.
  23. 23. Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J 2008 Feb;31(2):396-406.
  24. 24. Olveira G, Olveira C, Gaspar I, Porras N, Martin-Nunez G, Rubio E, et al. Fat-free mass depletion and inflammation in patients with bronchiectasis. J Acad Nutr Diet 2012 Dec;112(12):1999-2006.
  25. 25. Olveira G, Olveira C, Dorado A, Garcia-Fuentes E, Rubio E, Tinahones F, et al. Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clin Nutr 2013 Feb;32(1):112-117.
  26. 26. Wood LG, Garg ML, Simpson JL, Mori TA, Croft KD, Wark PA, et al. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 2005 Mar 1;171(5):426-430.
  27. 27. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc 2003 Nov;62(4):783-791.
  28. 28. Planas M, Alvarez J, Garcia-Peris PA, de la Cuerda C, de Lucas P, Castella M, et al. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients. Clin Nutr 2005 Jun;24(3):433-441.
  29. 29. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012 Dec 12;12:CD000998.
  30. 30. Constantin D, Menon MK, Houchen-Wolloff L, Morgan MD, Singh SJ, Greenhaff P, et al. Skeletal muscle molecular responses to resistance training and dietary supplementation in COPD. Thorax 2013 Mar 27.
  31. 31. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011 Oct 5;(10):CD005305. doi(10):CD005305.
  32. 32. Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J 2011 Feb;37(2):416-425.
  33. 33. Bhandari NJ, Jain T, Marolda C, ZuWallack RL. Comprehensive pulmonary rehabilitation results in clinically meaningful improvements in anxiety and depression in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2013 Mar-Apr;33(2):123-127.
  34. 34. Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012 Mar 14;3:CD008328.
  35. 35. Flude LJ, Agent P, Bilton D. Chest physiotherapy techniques in bronchiectasis. Clin Chest Med 2012 Jun;33(2):351-361.
  36. 36. Lee AL, Cecins N, Hill CJ, Holland AE, Rautela L, Stirling RG, et al. The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial. BMC Pulm Med 2010 Feb 2;10:5.
  37. 37. Murray MP, Pentland JL, Hill AT. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J 2009 Nov;34(5):1086-1092.
  38. 38. Mandal P, Sidhu MK, Kope L, Pollock W, Stevenson LM, Pentland JL, et al. A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Respir Med 2012 Dec;106(12):1647-1654.
  39. 39. Olveira G, Olveira C, Fernández-García JC, Espildora F. Soporte nutricional en el paciente con patología pulmonar, enfermedad pulmonar obstructiva crónica y fibrosis quística. In: Bellido D, De Luis D, editor. Manual de Metabolismo y Nutrición. ; 2009. p. 455-470.
  40. 40. van de Bool C, Steiner MC, Schols AM. Nutritional targets to enhance exercise performance in chronic obstructive pulmonary disease. Curr Opin Clin Nutr Metab Care 2012 Nov;15(6):553-560.
  41. 41. Laviolette L, Lands LC, Dauletbaev N, Saey D, Milot J, Provencher S, et al. Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study. J Med Food 2010 Jun;13(3):589-598.
  42. 42. Ringbaek T, Wilcke T. Rehabilitation and palliative care of patients with severe COPD must be integrated. Ugeskr Laeger 2013 Apr 29;175(18):1277-1280.
  43. 43. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005 Apr 18;(2)(2):CD000998.
  44. 44. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr 2012 Jun;95(6):1385-1395.
  45. 45. Itoh M, Tsuji T, Nemoto K, Nakamura H, Aoshiba K. Undernutrition in patients with COPD and its treatment. Nutrients 2013 Apr 18;5(4):1316-1335.
  46. 46. Ries AL. Pulmonary rehabilitation: summary of an evidence-based guideline. Respir Care 2008 Sep;53(9):1203-1207.
  47. 47. Martín-Valero R, Cuesta-Vargas AI, Labajos-Manzanares MT. Types of Physical Exercise Training for COPD patients. In: Kian-Chung Ong, editor. Chronic Obstructive Pulmonary Disease-Current Concepts and Practice Croacia:; 2012. p. 351-374.
  48. 48. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ 2006 Mar 14;174(6):801-809.
  49. 49. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985 Mar-Apr;100(2):126-131.
  50. 50. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011 Aug;140(2):331-342.
  51. 51. Scarborough P, Bhatnagar P, Wickramasinghe KK, Allender S, Foster C, Rayner M. The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs. J Public Health (Oxf) 2011 Dec;33(4):527-535.
  52. 52. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012 Apr;106(4):522-530.
  53. 53. Taylor NF, Dodd KJ, Shields N, Bruder A. Therapeutic exercise in physiotherapy practice is beneficial: a summary of systematic reviews 2002-2005. Aust J Physiother 2007;53(1):7-16.
  54. 54. Lan CC, Chu WH, Yang MC, Lee CH, Wu YK, Wu CP. Benefits of pulmonary rehabilitation in patients with COPD with normal exercise capacity. Respir Care 2013 Jan 3.
  55. 55. Walters JA, Cameron-Tucker H, Courtney-Pratt H, Nelson M, Robinson A, Scott J, et al. Supporting health behaviour change in chronic obstructive pulmonary disease with telephone health-mentoring: insights from a qualitative study. BMC Fam Pract 2012 Jun 13;13:55-2296-13-55.
  56. 56. Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res 2011 Mar 22;12:33-9921-12-33.
  57. 57. Arbillaga-Etxarri A, Gimeno-Santos J, Vilaró J, Vall-Casas J, García-Aymerich J. Diseño de Circuitos para el entrenamiento urbano en pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC). Archivos de Bronconeumologia 2013;Libro de Abstract 46 Congreso Nacional de SEPAR:74-75.
  58. 58. El Gobierno de Navarra y la Universidad Pública de Navarra. Guía de paseos por Pamplona para pacientes con EPOC. 2013.
  59. 59. Bártholo TP, Gomes MM, Noronha Filho AJ. DPOC-o impacto da oxigenoterapia domiciliar no tratamento. Pulmao 2009;1(1):79-84.
  60. 60. Jindal SK, Agarwal R. Long-term oxygen therapy. Expert Rev Respir Med 2012 Dec;6(6):639-649.
  61. 61. Nonoyama ML, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007 Apr 18;(2)(2):CD005372.
  62. 62. Cedano S, Bettencourt AR, Traldi F, Machado MC, Belasco AG. Quality of life and burden in carers for persons with Chronic Obstructive Pulmonary Disease receiving oxygen therapy. Rev Lat Am Enfermagem 2013 Jul-Aug;21(4):860-867.
  63. 63. van Helvoort HA, Heijdra YF, Heunks LM, Meijer PL, Ruitenbeek W, Thijs HM, et al. Supplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006 May 15;173(10):1122-1129.
  64. 64. Wijkstra PJ, Wempe JB. New tools in pulmonary rehabilitation. Eur Respir J 2011 Dec;38(6):1468-1474.
  65. 65. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003 Nov 1;168(9):1034-1042.
  66. 66. Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009 Aug;39(8):495-501.
  67. 67. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006 May;27(5):1040-1055.
  68. 68. Cortopassi F, Divo M, Pinto-Plata V, Celli B. Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients. Respir Med 2011 May;105(5):748-754.
  69. 69. Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012;7(6):e39198.
  70. 70. Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, et al. Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act 2012 Jul 9;9:84-5868-9-84.
  71. 71. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Remoortel HV, Giavedoni S, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013 Feb 8.
  72. 72. Marco E, Ramirez-Sarmiento AL, Coloma A, Sartor M, Comin-Colet J, Vila J, et al. High-intensity vs. sham inspiratory muscle training in patients with chronic heart failure: a prospective randomized trial. Eur J Heart Fail 2013 Aug;15(8):892-901.
  73. 73. Gea J, Casadevall C, Pascual S, Orozco-Levi M, Barreiro E. Respiratory diseases and muscle dysfunction. Expert Rev Respir Med 2012 Feb;6(1):75-90.
  74. 74. Strasser B, Siebert U, Schobersberger W. Effects of resistance training on respiratory function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Sleep Breath 2013 Mar;17(1):217-226.
  75. 75. Holland AE, Hill CJ, Jones AY, McDonald CF. Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012 Oct 17;10:CD008250.
  76. 76. Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J 2011 Feb;37(2):416-425.
  77. 77. Hill K, Jenkins SC, Philippe DL, Cecins N, Shepherd KL, Green DJ, et al. High-intensity inspiratory muscle training in COPD. Eur Respir J 2006 Jun;27(6):1119-1128.
  78. 78. Mota S, Guell R, Barreiro E, Solanes I, Ramirez-Sarmiento A, Orozco-Levi M, et al. Clinical outcomes of expiratory muscle training in severe COPD patients. Respir Med 2007 Mar;101(3):516-524.
  79. 79. Ramirez-Sarmiento A, Orozco-Levi M, Guell R, Barreiro E, Hernandez N, Mota S, et al. Inspiratory Muscle Training in Patients with Chronic Obstructive Pulmonary Disease: Structural Adaptation and Physiologic Outcomes. Am J Respir Crit Care Med 2002 December 1;166(11):1491-1497.
  80. 80. Laoutaris ID, Adamopoulos S, Manginas A, Panagiotakos DB, Kallistratos MS, Doulaptsis C, et al. Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study. Int J Cardiol 2013 Sep 1;167(5):1967-1972.
  81. 81. Charususin N, Gosselink R, Decramer M, McConnell A, Saey D, Maltais F, et al. Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial. BMJ Open 2013 Aug 5;3(8):10.1136/bmjopen-2013-003101.
  82. 82. Hogg L, Grant A, Garrod R, Fiddler H. People with COPD perceive ongoing, structured and socially supportive exercise opportunities to be important for maintaining an active lifestyle following pulmonary rehabilitation: a qualitative study. J Physiother 2012;58(3):189-195.
  83. 83. Hayton C, Clark A, Olive S, Browne P, Galey P, Knights E, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med 2013 Mar;107(3):401-407.
  84. 84. Norweg A, Bose P, Snow G, Berkowitz ME. A pilot study of a pulmonary rehabilitation programme evaluated by four adults with chronic obstructive pulmonary disease. Occup Ther Int 2008;15(2):114-132.
  85. 85. Lohne V, Heer HC, Andersen M, Miaskowski C, Kongerud J, Rustoen T. Qualitative study of pain of patients with chronic obstructive pulmonary disease. Heart Lung 2010 May-Jun;39(3):226-234.
  86. 86. Halding AG, Wahl A, Heggdal K. 'Belonging'. 'Patients' experiences of social relationships during pulmonary rehabilitation. Disabil Rehabil 2010;32(15):1272-1280.
  87. 87. Arnold E, Bruton A, Ellis-Hill C. Adherence to pulmonary rehabilitation: A qualitative study. Respir Med 2006 Oct;100(10):1716-1723.
  88. 88. Taylor SJ, Bogdan R. Introducción a los métodos cualitativos de investigación. 1ª Paidos ed. Barcelna; 1998.
  89. 89. Denzin NK and Lincoln Y. Handbook of Qualitative Research. California: Sage: Thousand Oaks; 1994.
  90. 90. Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. Sage ed. London; 2006.
  91. 91. Bulley C, Donaghy M, Howden S, Salisbury L, Whiteford S, Mackay E. A prospective qualitative exploration of views about attending pulmonary rehabilitation. Physiother Res Int 2009 Sep;14(3):181-192.
  92. 92. Cleland J, Moffat M, Small I. A qualitative study of stakeholder views of a community-based anticipatory care service for patients with COPD. Prim Care Respir J 2012 Sep;21(3):255-260.
  93. 93. Hamilton S, Huby G, Tierney A, Powell A, Kielmann T, Sheikh A, et al. Mind the gap between policy imperatives and service provision: a qualitative study of the process of respiratory service development in England and Wales. BMC Health Serv Res 2008 Dec 4;8:248-6963-8-248.
  94. 94. Williams V, Bruton A, Ellis-Hill C, McPherson K. The effect of pulmonary rehabilitation on perceptions of breathlessness and activity in COPD patients: a qualitative study. Prim Care Respir J 2010 Mar;19(1):45-51.
  95. 95. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009 Sep;18(3):208-215.
  96. 96. Keating A, Lee AL, Holland AE. Lack of perceived benefit and inadequate transport influence uptake and completion of pulmonary rehabilitation in people with chronic obstructive pulmonary disease: a qualitative study. J Physiother 2011;57(3):183-190.
  97. 97. Fairbrother P, Pinnock H, Hanley J, McCloughan L, Sheikh A, Pagliari C, et al. Exploring telemonitoring and self-management by patients with chronic obstructive pulmonary disease: A qualitative study embedded in a randomized controlled trial. Patient Educ Couns 2013 May 3.
  98. 98. Chan SC. Chronic obstructive pulmonary disease and engagement in occupation. Am J Occup Ther 2004 Jul-Aug;58(4):408-415.
  99. 99. American Occupational Therapy Association. Occupational Therapy framework: Domain and process (2nd ed.). Am J Occup Ther, 2008;62:625-683.
  100. 100. Fraguas Cerezo, MP. Terapia ocupacional en rehabilitación respiratoria. Ter ocup: Rev APETO, 2003; 31: 2-4.
  101. 101. Morgan DD, White KM. Occupational therapy interventions for breathlessness at the end of life. Am J Occup Ther, 2011;65(4):428-36.
  102. 102. Coll Artés, R. Estrategias para el manejo de los problemas de la vida diaria: Terapia Ocupacional, soporte psicosocial y sexualidad. En: Güell Rous R, de Lucas Ramos P (eds.). Rehabilitación respiratoria. Medical & Marketing Comunications. Madrid, 1999.p 217-31.
  103. 103. Ngo L, Latham NK, Jette AM, Soukup J, Lezzoni LI. Use of physical and occupational therapy by Medicare beneficiaries within five conditions: 1994-2001. Am J Phys Med Rehabil, 2009;88(4):308-321.
  104. 104. Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Moore R, et al. Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease-a multi-centre randomised controlled equivalence trial. BMC Pulm Med 2013 Sep 8;13:57-2466-13-57.

Written By

R. Martín-Valero, M.C. Rodríguez-Martínez, R. Cantero-Tellez, E. Villanueva-Calvero and F. Fernández-Martín

Submitted: September 18th, 2013 Published: July 16th, 2014